Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation.
Department of Pharmacy, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
Pharmazie. 2021 Apr 1;76(4):132-137. doi: 10.1691/ph.2021.0904.
To investigate structure-activity relationships of tankyrase (TNKS) inhibitors, twelve new derivatives of isoquinolin-1(2 H )-one were designed and synthesized, and biological assessments were conducted. Several potent TNKS inhibitors with single- or double-digit nanomolar IC50 values were identified using enzymatic assays. Compound 11c was the most potent compound of this series and inhibited TNKS1 and TNKS2 at an IC50 of 0.009 and 0.003 μM, respectively, and showed an IC50 of 0.029 μM in a DLD-1 SuperTopFlash assay. Molecular docking results showed that compound 11c occupied a unique subpocket and formed a hydrogen bond with Glu1138 of TNKS2, which was not consistent with the patterns of known TNKS inhibitors and thus warrants further research.
为了研究端锚聚合酶(TNKS)抑制剂的构效关系,设计并合成了十二种新的异喹啉-1(2H)-酮衍生物,并进行了生物评估。通过酶促测定法,鉴定出几种具有单或双位数纳摩尔 IC50 值的强效 TNKS 抑制剂。化合物 11c 是该系列中最有效的化合物,对 TNKS1 和 TNKS2 的抑制作用分别为 0.009 和 0.003 μM,在 DLD-1 SuperTopFlash 测定中,IC50 为 0.029 μM。分子对接结果表明,化合物 11c 占据了一个独特的亚口袋,并与 TNKS2 的 Glu1138 形成氢键,这与已知的 TNKS 抑制剂的模式不一致,因此值得进一步研究。